Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.
Powers RK, Culp-Hill R, Ludwig MP, Smith KP, Waugh KA, Minter R, Tuttle KD, Lewis HC, Rachubinski AL, Granrath RE, Carmona-Iragui M, Wilkerson RB, Kahn DE, Joshi M, Lleó A, Blesa R, Fortea J, D'Alessandro A, Costello JC, Sullivan KD, Espinosa JM.
Powers RK, et al.
Nat Commun. 2019 Oct 18;10(1):4766. doi: 10.1038/s41467-019-12739-9.
Nat Commun. 2019.
PMID: 31628327
Free PMC article.